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Introduction
　Atrial brillation （AF） is a common sustained arrhythmia encountered in clinical prac-
tice 1）.  AF prevalence is increasing due to a combination of factors including an ageing 
population, the rising prevalence of chronic heart disease, and more frequent diagnosis 
through the use of ambulatory monitoring devices 2, 3）.  Radiofrequency percutaneous catheter 
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Abstract : We investigated whether right atrial （RA） volume could be used to 
predict the recurrence of atrial brillation （AF） after pulmonary vein catheter 
ablation （CA）.  We evaluated 65 patients with paroxysmal AF （mean age, 
60＋ 10 years, 81.5％ male） and normal volunteers （57 ± 14 years, 41.7％ 
male）.  Sixty-four-slice multi-detector computed tomography was performed for 
left atrial （LA） and RA volume estimations before CA.  The recurrence of 
AF was assessed for 6 months after the ablation.  Both left and right atrial 
volumes were larger in the AF patients than the normal volunteers （LA : 
99.7＋ 33.2 ml vs. 59.7＋ 17.4 ml ; RA : 82.9＋ 35.7 ml vs. 43.9＋ 12 ml ; P＜
0.0001 for both）.  A total of 16 patients （24.6 ％） showed recurrence of AF, 
involving both atrial volumes （LA : 125.8＋ 36.9 ml in patients AF recurrence 
vs. 91.1 ＋ 27.1 ml in 49 patients with no recurrence, P ＝ 0.001 ; RA : 117.5 ＋ 
40.9 ml vs. 71.6＋ 25.5 ml, P＜ 0.0001）.  The sensitivity with large LA vol-
umes （＞100 ml） for predicting the recurrence of AF was 81.3％ in 13 of 
16 patients with AF recurrence, and the specificity was 69.4％ in 34 of 49 
patients without recurrence.  The sensitivity with large RA volumes （＞ 87 ml） 
was 81.3％ in 13 of 16 patients with AF recurrence, and the specificity was 
75.5％ in 37 of 49 patients without recurrence.  RA volume is a useful predic-
tor of the recurrence of AF, similar to LA volume.
Key words : atrial brillation, catheter ablation, multi-detector computed tomo-
graphy, atrial volume
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ablation （CA） of AF with pulmonary vein isolation is currently the standard therapy for 
selected patients 4, 5）.  It is also considered as first-line therapy for symptomatic patients 
with paroxysmal AF, small left atrial （LA） dimensions, and no evidence of structural heart 
disease4-6）.  An enlarged LA volume is a known predictor of AF recurrence after CA in 
patients with AF 1, 7）.  Multidetector （MD） computed tomography （MDCT） allows multidi-
mensional reconstruction of patient-specic cardiac anatomy1, 8）.  CT-rendered volumes add a 
third dimension to an otherwise two-dimensional ablation procedure, allowing better delinea-
tion of the LA anatomy with precise volume estimation and increased electroanatomical 
mapping accuracy9, 10-12）.  However, patients with AF also show increased right atrium （RA） 
volumes13）.  We therefore, we investigated whether measuring of RA volume is useful for 
predicting the recurrence of AF.
Methods
Study Population
　This study enrolled patients with a history of palpitations and diagnosed with paroxysmal 
AF from April 2008 to November 2009 at Showa University Hospital.  Arrhythmia was 
diagnosed on the basis of documented AF by ambulance monitoring, 12-lead electrocardi-
ography （ECG）, or Holter monitoring.  A nal diagnosis of AF was made when visible P 
wave were absent on all 12-leads of the ECG and an irregular random ventricular response 
was present.  AF was considered paroxysmal if the brillatory process ended spontaneously 
after some seconds, minutes, hours, or up to 7 days 4）.  Those patients with persistent （not 
self terminating, but recovery to sinus rhythm following therapy） or permanent AF were 
not enrolled in this study.  Left ventricular ejection fraction （LVEF） was measured by two-
dimensional echocardiography before the study and patients with LVEF ＜ 50％, history of 
valvular disease including of rheumatic cause, congenital heart disease, ischemic heart disease, 
or cardiomyopathy were also excluded.  Patients were also excluded from this study if they 
had pre-excitation syndrome, atrioventricular tachycardia or ventricular tachyarrhythmia, atrial 
utter, or a pacemaker implanted before the study.  All patients underwent transesophageal 
echocardiography 24-72 hours before the procedure of pulmonary vein CA to exclude 
the presence of LA thrombus.  Finally, 65 patients （mean ± standard deviation, age : 60±
10 years, 81.5％ males） with paroxysmal AF without structural heart disease and with 
preserved cardiac function were recruited for the nal study cohort.  Twelve normal healthy 
volunteers were also recruited as the control group （57 ± 14 years, 41.7％ male）.  Sixty-
four MDCT scanning was performed systematically up to 1 week before the procedure, 
for electroanatomical mapping integration 14）, pulmonary vein anatomy delineation, and 
atrial volume estimations.  Scanning was performed in a single breath hold in the cranio-
caudal direction from aortic arch to diaphragm, being gated to the cardiac cycle through 
ECG synchronization.  The pulmonary vein CA procedure was guided by CARTO merge 
electroanatomical mapping14）.  Three catheters were introduced via the right femoral vein 
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under local anesthesia, supplemented by sedation when necessary.  An irrigated-tip ablation 
catheter and a duodecapolar circular mapping catheter were placed at the pulmonary vein 
ostia via transeptal access.  Irrigated-radiofrequency ablation was performed with continuous 
lesions encircling both pulmonary veins and deployed more than 5 mm from the pulmonary 
vein ostia 4）.  Thus, the patients were submitted to complete isolation of all the pulmonary 
veins by a conventional procedure.  Clinical success or recurrence of AF was assessed for 6 
months, after the ablation, dened by the absence or presence, respectively, of symptomatic 
or documented AF by periodic electrocardiography and at least one 24-hour Holter monitor-
ing after ablation.  All patients gave written informed consent before this study, and the 
protocol was approved by our Institutional Review Board.  Data collected prospectively 
included demographics, existing medical diagnoses, symptoms, risk factors for vascular disease, 
medications, previous cardiac procedures, and prior history of vascular event.
Scan Protocol and Data Acquisition of MDCT
　All patients were scanned with a 64-slice scanner （SOMATOM Sensation 64 Cardiac, 
Siemens Medical Solutions, Forchheim, Germany）.  A bolus of contrast media （Omnipaque, 
350 mg iodine / ml, Daiichi Pharmaceutical Co, Tokyo, Japan） was injected into an antecubital 
vein, followed by flushing with 20-50 ml of saline.  The amount of contrast media used 
for the scan was determined according to the patient’s body weight and scan time as fol-
lows : total dose＝（scan time＋ 4 second）× 0.07 × body weight.  The region of interest was 
placed within the ascending aorta and the scan was started when the CT density was 150 
Hounseld units higher than the baseline CT.  The scan was performed between aortic arch 
and diaphragm with the following parameters : collimation width 64×0.6 mm ; rotation time 
330 ms ; tube voltage 120 kV ; effective tube current 800 mAs ; table feed 11.5 mm / rotation, 
and pitch 0.2.  Image reconstruction was retrospectively gated to an ECG, and ECG-gated 
datasets were reconstructed with a slice thickness of 0.75 mm and a interval of 0.7 mm at 
the point of 330 msec of the cardiac cycle before QRS complex 14, 15）.
　LA and RA volumes were measured using OsiriX software as an application for the 
MacOS X operating system （version 3.3.2）16） （Fig. 1）.  Each short-axis CT image for the 
interval of 0.7 mm was picked up, and the region of interest was set up on the LA and 
RA areas.  Thus, LA and RA volumes were quantitatively calculated from three-dimensional 
images using OsiriX software17） （Fig. 2）.  Measurements were performed without knowledge 
of the clinical history.  To assess interobserver variability, the LA volume measurements were 
repeated by a second reviewer blind to the ndings of the rst observer ; there was an 
excellent correlation between those measurement sets （P＜ 0.0001）.
Statistical Analysis
　For descriptive purposes, the patients were divided into two groups on the basis of the 
predictors such as LA or RA volumes.  Continuous variables were presented as means±
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standard deviation.  Differences between groups （successful pulmonary vein ablation groups, 
AF recurrence group, and control group） were tested using ANOVA, the post-hoc test, the 
paired t-test, or the chi-square test, as appropriate.  Receiver operating characteristic analysis 
was performed to dene thresholds for those predictors ; this analysis provided optimal sensi-
tivity and specicity in predicting the recurrence of AF.  The association between large atrial 
volume and recurrence of AF after CA was formally tested by construction of multivariate 
logistic regression analysis.  The statistical analysis was done using SPSS for Windows version 
11 （SPSS Inc, Chicago, IL）.  A P value＜ 0.05 was considered signicant.
Fig. 1.   Three-dimensional renderings of left atrium and 
pulmonary veins.
Fig. 2.   The evaluation of left atrial（LA） and right 
atrial （RA）volumes. Semi-automatic software 
with atrium endocardial contour, automatic 
detection, and operator correction using OsiriX 
soft software.
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Results
Patient Characteristics
　Over the 6-month follow-up, 16 patients showed recurrence of AF （24.6％）, and 49 
patients had no recurrence.  The patients with AF recurrence showed significantly larger 
RA and LA volumes than the patients without recurrence, but there were no signicant 
differences between the patients with and without recurrence of AF in age, gender, cardio-
vascular risk factors, and hemodynamic responses （Table 1）.  Body mass index was higher 
in the patients with AF recurrence than in those without, but these risk factors such as 
obesity and hypertension were controlled by diet, salt restriction, and medication after the 
start of this study.  No patients had a history of alcohol abuse, genetic factors, or sleep 
apnea.  There was no signicant difference between the group in inammatory markers such 
Table 1.  Patient Characteristics and the recurrence of Atrial Fibrillation after Pulmonary Vein Catheter Ablation
Variable
No recurrence of AF
（n＝ 49）
Recurrence of AF
（n＝ 16） P value
Age （years） 62 ± 10 59 ± 10 p＝N.S.
Male 38 （78％） 15 （94％） p＝N.S
History of diabetes  7 （14％）  2 （13％） p＝N.S
History of hypertension 23 （47％）  8 （50％） p＝N.S
BMI 23.7 ± 2.89 26.3 ± 2.68 p＝ 0.002
Echocardiographic ndings  
　Left ventricular ejection fraction （％） 61.5 ± 7.9 59.2 ± 7.7 p＝N.S
　Deceleration time （msec） 205 ± 46 206 ± 49 p＝N.S
Resting hemodynamics
　Resting HR （bpm） 66 ± 9 66 ± 7 p＝N.S
　Resting systolic BP （mmHg） 132 ± 12 123 ± 11 p＝N.S
　Resting diastolic BP （mmHg） 73 ± 9 72 ± 9 p＝N.S
Laboratory data
　CRP （mg / dl） 0.3 ± 0.4 0.2 ± 0.1 p＝N.S.
　BNP （pg / dl） 70.3 ± 79.6 87.5 ± 91.2 p＝N.S.
Medications
　Use of angiotensin-converting enzyme inhibitor 15 （31％）  7 （44％） p＝N.S
　Use of beta-blocker 11 （22％）  3 （18％） p＝N.S
　Use of calcium channel antagonist 14 （29％）  3 （19％） p＝N.S
　Use of digoxin  9 （18％）  2 （13％） p＝N.S
　Use of diuretic drug  3  （6％）  3 （19％） p＝N.S
Quantitative MDCT data  
　Left atrial dimension （ml） 125.8 ± 36.9 91.1 ± 27.1 p＜0.0001
　Right atrial dimension （ml） 117.5 ± 40.9 71.6 ± 25.5 p＜0.0001
Abbreviation : BMI＝ Body Mass Index, HR＝Heart rate, BP＝ Blood pressure, CRP＝ Serum concentration 
of C-Reactive Protein, BNP＝ the plasma Brain Natriuretic Peptide level, MDCT＝Multi-detector Computed 
Tomography, N.S＝Not Signicant.
Kyouichi KANEKO, et al78
as serum C-reactive protein or neurohumoral biomarkers such as plasma brain natriuretic 
peptide.  No medications were associated with the recurrence of AF.
　Before CA, both atrial volumes were significantly larger in the AF patients than in 
normal volunteers （LA : 99.7＋ 33.2 ml vs. 59.7＋ 17.4 ml, and RA : 82.9＋ 35.7 ml vs. 
43.9＋ 12 ml）.  Further, both RA and LA volumes were associated with the recurrence of 
AF （LA : 125.8＋ 36.9 ml in patients with AF recurrence vs. 91.1＋ 27.1 ml in 49 patients 
without recurrence, and RA : 117.5＋ 40.9 ml vs 71.6＋ 25.5 ml, respectively） （Fig. 3）.
LA and RA Volumes for Predicting the Recurrence of AF
　Optimal thresholds for predicting the recurrence of AF were at LA volume ＝ 99.4 ml 
and RA volume＝ 87.6 ml （Fig. 4）.  The sensitivity of increased LA volumes （＞ 100 ml） 
for predicting the recurrence of AF was 81.3％ in 13 of 16 patients with recurrence, and 
the specicity was 69.4％ in 34 of 49 patients without recurrence of AF.  The sensitivity of 
increased RA volumes （＞ 87 ml） was 81.3％ in 13 of 16 patients with recurrence, and the 
specicity was 75.5％ in 37 of 49 patients without recurrence of AF.  Further, LA and RA 
volumes were closely correlated （r＝ 0.404, P＝ 0.001）.  In multivariate analysis, both LA 
and RA volumes were independent and signicant predictors of successful CA with hazard 
ratios of 9.8 ［95％ CI 2.4 to 39.6］ and 13.4 ［95％ CI 3.2 to 54.9］ after adjustment for 
potential confounding variables such as age, gender, coronary risk factors, and medications.
Fig. 3.   Comparison of left atrial （LA） and right atrial （RA） volumes 
between idiopathic paroxysmal AF patients with and without 
recurrence of AF and normal healthy volunteers.
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Discussion
　This study demonstrated that RA volume measured by MDCT could predict the recur-
rence of AF after CA with a sensitivity and specicity similar to LA volume measurement.
　LA size is an established predictor of AF recurrence and maintenance after electrical 
cardioversion because AF induces electrical and structural remodeling of the brillating atria, 
perpetuating AF3, 4）.  However, the signicance of RA volume was not claried in previous 
studies despite both volumes increasing symmetrically in patients with AF 13）.  In a 6-month 
follow-up study by ECG in patients with AF, Shin et al 18） found that LA volume increases 
over 34 ml / m2 predicted recurrence of AF after CA with a sensitivity of 70％ and specic-
ity of 91％.  However, the same study concluded that RA volume measurements were less 
signicant predictors of AF recurrence by multivariate analysis.  Their study was new and 
noteworthy in even suggesting the use of RA volume for predicting AF recurrence after 
CA, but it had some limitations.  First, the evaluation did not separate paroxysmal AF 
and permanent AF.  Paroxysmal AF is frequently a purely trigger-dependent phenomenon, 
Fig. 4.   Receiver operating characteristics （ROC） curve. Success after catheter ablation of AF for left atrial （LA） 
and right atrial （RA） volumes measured by 64-multislice detector computed tomography （MDCT）.
Table 2.  Prediction of the Recurrence of Atrial Fibrillation after Pulmonary 
Vein Catheter Ablation According to Multivariate Analysis
Variable Success CA （％） Odd ratio Wald P value
Present Absent （95％ CI） χ2
Large LA volume（＞ 100 ml） 13 / 28 （46.4％） 3 / 37 （8.1％） 9.8 （2.4-39.6） 10.3 p＝ 0.001
Large RA volume（＞ 87 ml） 13 / 25 （52％） 3 / 40 （7.5％） 13.4 （3.2-54.9） 12.9 p＜0.0001
Abbreviations : CA＝ Catheter ablation, CI＝ Condence interval, LA＝ Left atrium, RA＝Right atrium.
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whereas permanent AF is mechanistically complex, implicating a more diffuse abnormality of 
the atrial substrate4）.  Second, the ECG could not always accurately measure atrial enlarge-
ment due to multivariate variations in the atrium, and in particular, the right atrium 19）. 
Therefore, we used MDCT in the current study because it quanties atrial volume 3 dimen-
sionally19）.  Helms et al 11） also showed in a 12-month follow-up study using MDCT that 
large LA volume （＞ 135 ml） is a predictor of AF recurrence with a sensitivity of 36％ and 
specicity of 96％ ; however, their study subjects also included patients with permanent AF.
　To our knowledge, we present herein the rst quantitative evaluation of both left and 
right atrial volumes for predicting the recurrence of AF after CA using MDCT and quan-
titative three-dimensional measurement software.  The sensitivity of prediction for large LA 
volumes （＞ 100 ml） was 81.3％, and the specicity was 69.4％ in patients with paroxysmal 
AF.  More importantly, the sensitivity of prediction for large RA volumes （＞ 87 ml） 
was 81.3％ and the specicity was 75.5％.  In addition, the precise three-dimensional atrial 
reconstruction by the OsiriX software allows for a computer-aided and navigation-aided 
quantitative measurement of atrial volume 16, 17）.  AF is maintained by microreentrant sources 
located in the LA20, 21） with brillatory conduction toward the RA22）.  Therefore, the RA 
was thought to be a bystander during maintenance or recurrence of AF, while the LA 
underwent a change typical of both paroxysmal and permanent AF.  Recently, we reported 
the signicance of sympathetic nervous system abnormality for predicting perpetuated AF 
in patients with paroxysmal AF23）, and the magnitude of nerve sprouting and hyperin-
nervation has been reported to be higher in the RA than in the LA in a canine model of 
AF produced by prolonged RA pacing, further suggesting the signicance of RA 24）.  The 
percentage area occupied by brosis was also recently shown to be higher in the LA than 
in the RA of patients who developed AF, suggesting more reversible and quick changes to 
the right atrium 25）.  Our result thus conrms that RA volume is important for morbidity in 
patients with AF.  Finally, MDCT is a guide to invasive intervention in patients with coro-
nary artery disease26, 27） and rhythm disorders14）, and our results indicated the signicance of 
three-dimensional and quantitative evaluation of RA size using a computer-aided technique 
with 64-slice MDCT.
　The present study compared atrial volumes with those measured similarly in previous 
studies with respect to the recurrence of AF1, 4, 13, 28）.  Other studies used the value of atrial 
volume indexed to body mass or body surface area 18）.  Obesity is an important risk factor 
for the development of AF, while body weight is closely correlated to LA volume, and 
weight reduction has been linked to regression of LA enlargement4, 29）.  Furthermore, the 
atrial volume index correlated by body mass or body surface area was less signicant com-
pared to the value of direct atrial volume measurement used herein and elsewhere because 
the atrial volumes were independent of body mass value28）.  Similarly, we did not use the 
weight index because atrial volume correlated with body mass index in the present study.
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